SMG1 and pancreatic adenocarcinoma: In particular, the stratification of cancer patients based on tumor SMG1 expression led to survival predicted p-values of 0.0017 for PAAD, 0.0019 for LUAD and 0.0047 for BRCA (Fig. 1B).